僅用于工業(yè)應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Crizanlizumab is an anti-P-selectin monoclonal antibody. Crizanlizumab binds to P-selectin and blocks its interaction with P-selectin glycoprotein ligand 1 （PSGL-1）. Crizanlizumab prevents vaso-occlusive crises （VOCs） and can be used for research of sickle cell disease